| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |